Boston, MA -- (SBWIRE) -- 09/16/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Boyd Gaming Corporation (NYSE:BYD), Gray Television, Inc. (NYSE:GTN), Atlantic Tele-Network, Inc. (NASDAQ:ATNI), TherapeuticsMD Inc (NYSEMKT:TXMD)
Boyd Gaming Corporation (NYSE:BYD) shares gained 4.90% to $13.27. Levi & Korsinsky, LLP on August 27 said it is investigating Boyd Gaming Corporation (BYD) in connection with possible claims of breaches of fiduciary duty.
Additionally, On August 14, 2013, Boyd Gaming Corporation entered into a Third Amended and Restated Credit Agreement (the "New Credit Agreement") among the Company, certain financial institutions, Bank of America, N.A., as administrative agent and letter of credit issuer, and Wells Fargo Bank, National Association, as swing line lender.
Is BYD A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Gray Television, Inc. (NYSE:GTN) stock climbed 4.79% to $7. The company on Sept. 4 announced the consumer launch of all of its Big Four affiliated channels on the Syncbak app.
As a result, in-market consumers who download the mobile Syncbak app to their tablets or smartphones may now watch their local Gray station during time periods when the channels broadcast their licensed programming. Gray's stations are not offering any content from a Big Four network through Syncbak at this time. With Syncbak's geo-located authentication technology, consumers are only able to view channels while physically located within the television market of the station providing its signal via the Syncbak app.
Is GTN A Good Buy After The Recent Price Movement? Find Out Here
Atlantic Tele-Network, Inc. (NASDAQ:ATNI) stock climbed 4.71% to $50.28. The company on Sept. 12 announced that its Board of Directors has declared a quarterly dividend of $0.27 per share, payable on October 7, 2013, on all common shares outstanding to stockholders of record as of September 30, 2013. This is the fifteenth consecutive annual increase in the Company's dividend and represents an increase of two cents, or 8%, over the dividend paid in the previous quarter.
How Should Investors Trade ATNI After The Recent Volatility? Get Free Report Here
TherapeuticsMD Inc (NYSEMKT:TXMD) stock gained 4.58% to $2.51. The company on Sept. 5 announced the enrollment and dosing of the first patient in the REPLENISH Trial, a Phase 3 clinical trial designed to measure the safety and effectiveness of TX 12-001-HR, the Company's bioidentical combination 17ß-estradiol and progesterone drug candidate, in treating the symptoms of menopause. Clinical endpoints of the REPLENISH Trial (www.ReplenishTrial.com) include measuring the reduction in frequency and severity of hot flashes over a 90-day period while ensuring endometrial protection for one year, in accordance with FDA Guidance for Estrogen/Progestins.
How Should Investors Trade TXMD After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)